The ECMC (Experimental Cancer Medicine Centre) meeting in Liverpool seeks to provide all the necessary background, evidence and clinical use for Immunotherapy in head and neck cancer and would be of use to trainees of all levels. This new drug modality has the potential to be a game changer in the treatment of head and neck squamous cell carcinoma.
It is on Friday the 16th March, 2018.
The rate for trainees has been kept at £80 to try and ensure this meeting is of interest to all.
Mr Andrew Schache PhD FDSRCS FRCS(OMFS)Clinical Senior Lecturer in Head & Neck Surgery, Northwest Cancer Research Centre, University of Liverpool
Honorary Consultant in Oral & Maxillofacial – Head & Neck Surgery, Maxillofacial Unit, Aintree University Hospitals NHS Foundation Trust